Literature DB >> 17132259

Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004).

Teri L Martin1, Karen L Woodall, Barry A McLellan.   

Abstract

In order to characterize fentanyl-related deaths in the province of Ontario, Canada, a retrospective study of all cases in which fentanyl was quantitated in blood was conducted for the time period between 2002 and 2004. A total of 112 fentanyl-related deaths were identified. Decedents ranged in age from 4 to 93 years and comprised 63 men and 49 women. A variety of routes of administration of the drug were identified: transdermal application of Duragesic patches, intravenous injection of patch contents or fentanyl citrate solution, oral/transmucosal administration, and volatilization and inhalation of Duragesic systems. Blood fentanyl concentrations were determined for all modes of drug administration and are provided. There were 54 cases in which death was attributed solely to fentanyl intoxication; the mean blood concentration was 25 microg/L (range: 3.0-383 microg/L). This concentration range overlapped with blood fentanyl concentrations measured among cases where the presence of the drug was considered incidental. For example, a mean blood concentration of 12 microg/L was observed among 12 cases of natural death (range: 2.7-33 microg/L). Detailed case reports of six individuals are also included and provide additional insight into the use of this drug for both therapeutic and illicit means.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132259     DOI: 10.1093/jat/30.8.603

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  32 in total

1.  ACMT Position Statement: Safety Issues Regarding Prescription Fentanyl Products.

Authors: 
Journal:  J Med Toxicol       Date:  2016-06

2.  Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development.

Authors:  Benedikt Fischer; Jürgen Rehm; Brian Goldman; Svetlana Popova
Journal:  Can J Public Health       Date:  2008 May-Jun

3.  Antemortem and postmortem fentanyl concentrations: a case report.

Authors:  Iain M McIntyre; Ray D Gary; Julio Estrada; Craig L Nelson
Journal:  Int J Legal Med       Date:  2013-07-24       Impact factor: 2.686

Review 4.  Bioequivalence criteria for transdermal fentanyl generics: do these need a relook?

Authors:  Carmen Walter; Lisa Felden; Jörn Lötsch
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  An epidemic of fatal 3-methylfentanyl poisoning in Estonia.

Authors:  Ilkka Ojanperä; Merja Gergov; Milana Liiv; Aime Riikoja; Erkki Vuori
Journal:  Int J Legal Med       Date:  2008-04-03       Impact factor: 2.686

6.  Deaths related to the use of prescription opioids.

Authors:  Benedikt Fischer; Jürgen Rehm
Journal:  CMAJ       Date:  2009-12-07       Impact factor: 8.262

7.  Quantitation of Fentanyl Analogs in Dried Blood Spots by Flow-Through Desorption Coupled to Online Solid Phase Extraction Tandem Mass Spectrometry.

Authors:  Rebecca L Shaner; Nicholas D Schulze; Craig Seymour; Elizabeth I Hamelin; Jerry D Thomas; Rudolph C Johnson
Journal:  Anal Methods       Date:  2017-06-16       Impact factor: 2.896

8.  Prevalence and correlates of nonmedical prescription opioid use among a cohort of sex workers in Vancouver, Canada.

Authors:  Elena Argento; Jill Chettiar; Paul Nguyen; Julio Montaner; Kate Shannon
Journal:  Int J Drug Policy       Date:  2014-07-31

9.  Toxicological testing when evaluating fatal cases suspected of acute fentanyl toxicity.

Authors:  Xiulu Ruan; Srinivas Chiravuri; Alan D Kaye
Journal:  Forensic Sci Med Pathol       Date:  2016-07-07       Impact factor: 2.007

10.  Route of administration for illicit prescription opioids: a comparison of rural and urban drug users.

Authors:  April M Young; Jennifer R Havens; Carl G Leukefeld
Journal:  Harm Reduct J       Date:  2010-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.